title: Lysosomal solute carrier transporters gain momentum in research.
abstract: Emerging evidence indicates that lysosome function extends beyond macromolecular degradation. Genetic and functional defects in components of the lysosomal transport machinery cause lysosomal storage disorders implicating the lysosomal solute carrier (SLC) transporters as essential to vital cell processes. The pathophysiology and therapeutic potential of lysosomal SLC transporters are highlighted here, focusing on recent discoveries in autophagic amino acid sensing (SLC38A9), phagocytic regulation in macrophages (SLC29A3, SLC15A3/A4), adenosine triphosphate (ATP) exocytosis in neurotransmission (SLC17A9), and lysosomal transport of maytansine catabolites into the cytoplasm (SLC46A3).
authors.affiliation: Division of Pharmaceutics & Pharmaceutical Chemistry, Ohio State University, Columbus, Ohio, USA. dikshit.3@osu.edu.
authors.forename: B
authors.initials: B
authors.lastname: Bissa
authors.affiliation: Department of Pharmaceutical Sciences, University of Georgia, Athens, Georgia, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Beedle
authors.affiliation: Division of Pharmaceutics & Pharmaceutical Chemistry, Ohio State University, Columbus, Ohio, USA.|Translational Therapeutics, Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
authors.forename: R
authors.initials: R
authors.lastname: Govindarajan
mesh_terms: D001343:Autophagy / Q000502:physiology; D005089:Exocytosis / Q000502:physiology; D006801:Humans; D008247:Lysosomes / Q000502:physiology*; D008954:Models, Biological; D058990:Molecular Targeted Therapy / Q000379:methods; D010587:Phagocytosis / Q000502:physiology; D000070590:Solute Carrier Proteins / Q000502:physiology*
chemical_list: D000070590:Solute Carrier Proteins